Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 21-30 of 30

Page
per page
  1. 7-Ethyl-10-hydroxycamptothecin
    N2133 7-Ethyl-10-hydroxycamptothecin
    Target: Topoisomerases
    Summary: TOPO I inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  2. Dihydroberberine
    N2078 Dihydroberberine
    Summary: Pancreatic lipase inhibitor
      Soluble to 57.46 mg/l in water
  3. Baicalein
    N1858 Baicalein
    Summary: Lipoxygenases inhibitor
      insoluble in H2O; ≥10.9 mg/mL
  4. Epiberberine
    N2453 Epiberberine
    Summary: BACE1 inhibitor
      insoluble in EtOH; ≥12.7 mg/mL
  5. Nicotinamide
    N1651 Nicotinamide
     1 Citation
    Target: PARP
    Summary: PARP-1 inhibitor
  6. Cryptotanshinone
    N1843 Cryptotanshinone
    Summary: STAT3/AChE inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.23 mg/mL
  7. Sennoside A
    N1678 Sennoside A
    Target: Monoamine oxidases (MAOs)
    Summary: Irritant laxative;mild MAO inhibitor
      ≥39.9 mg/mL
  8. Saikosaponin A
    N1885 Saikosaponin A
    Summary: COX-2 and iNOS inhibitor
      ≥39.05 mg/mL
  9. Paeonol
    N1847 Paeonol
    Summary: MAO inhibitor;multi-functional phenolic compound
  10. Berbamine hydrochloride
    N2471 Berbamine hydrochloride
    Summary: Anticancer drug,novel inhibitor of NF-κB activity
      ≥68 mg/mL

Items 21-30 of 30

Page
per page